Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Becher

Showing results (141-150 of 198) with videos related to

Pageof 20
Sort By:
Seminars in Oncology|February 1, 1989
Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancerR Becher, H Höfeler, O Kloke, et al.
Blut|April 1, 1984
Clonal evolution with isodicentric Ph1 chromosome in Ph1-positive CML: karyotypic conversion after bone marrow transplantationR Becher, S Ohl, U W Schaefer, et al.
Seminars in Oncology|December 1, 1995
Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysisU Klaassen, H Wilke, C P Pari, et al.
Acta Haematologica|January 1, 1994
Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remissionL Diekmann, D W Beelen, K Quabeck, et al.
Cancer Genetics and Cytogenetics|September 1, 1988
Translocation t(8;16) in acute monocytic leukemiaR Becher, O A Haas, U Graeven, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patientsN Niederle, T Moritz, O Kloke, et al.
Blood|January 1, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trialA Ganser, B Völkers, J Greher, et al.
Oncology|January 1, 1991
Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancerR Becher, H Höfeler, O Kloke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II studyK Höffken, W Jonat, K Possinger, et al.
Blood|November 1, 1991
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gammaB Opalka, U B Wandl, R Becher, et al.
Pageof 20

Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
Seminars in Oncology|February 1, 1989
Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancerR Becher, H Höfeler, O Kloke, et al.
Blut|April 1, 1984
Clonal evolution with isodicentric Ph1 chromosome in Ph1-positive CML: karyotypic conversion after bone marrow transplantationR Becher, S Ohl, U W Schaefer, et al.
Seminars in Oncology|December 1, 1995
Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysisU Klaassen, H Wilke, C P Pari, et al.
Acta Haematologica|January 1, 1994
Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remissionL Diekmann, D W Beelen, K Quabeck, et al.
Cancer Genetics and Cytogenetics|September 1, 1988
Translocation t(8;16) in acute monocytic leukemiaR Becher, O A Haas, U Graeven, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patientsN Niederle, T Moritz, O Kloke, et al.
Blood|January 1, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trialA Ganser, B Völkers, J Greher, et al.
Oncology|January 1, 1991
Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancerR Becher, H Höfeler, O Kloke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II studyK Höffken, W Jonat, K Possinger, et al.
Blood|November 1, 1991
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gammaB Opalka, U B Wandl, R Becher, et al.
Pageof 20